Balyasny Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,264
Closed -$1.1M 2513
2025
Q1
$1.1M Sell
2,264
-133,559
-98% -$64.8M ﹤0.01% 1326
2024
Q4
$54.7M Buy
135,823
+81,351
+149% +$32.8M 0.08% 223
2024
Q3
$25.3M Buy
54,472
+52,180
+2,277% +$24.3M 0.04% 404
2024
Q2
$1.07M Sell
2,292
-185,844
-99% -$87.1M ﹤0.01% 1217
2024
Q1
$78.6M Buy
188,136
+183,380
+3,856% +$76.7M 0.14% 127
2023
Q4
$1.94M Buy
4,756
+873
+22% +$355K ﹤0.01% 1043
2023
Q3
$1.35M Buy
3,883
+159
+4% +$55.3K ﹤0.01% 1090
2023
Q2
$1.31M Sell
3,724
-35,245
-90% -$12.4M ﹤0.01% 1144
2023
Q1
$12.3M Buy
38,969
+1,148
+3% +$362K 0.03% 554
2022
Q4
$10.9M Buy
+37,821
New +$10.9M 0.03% 559
2022
Q3
Hold
0
2772
2022
Q2
Sell
-19,312
Closed -$5.04M 2738
2022
Q1
$5.04M Sell
19,312
-192,035
-91% -$50.1M 0.02% 735
2021
Q4
$46.4M Buy
211,347
+56,709
+37% +$12.5M 0.16% 131
2021
Q3
$28.1M Buy
+154,638
New +$28.1M 0.12% 218
2021
Q2
Hold
0
2096
2020
Q3
Sell
-4,249
Closed -$1.23M 1390
2020
Q2
$1.23M Buy
+4,249
New +$1.23M 0.01% 631
2020
Q1
Sell
-159,396
Closed -$34.9M 1422
2019
Q4
$34.9M Buy
+159,396
New +$34.9M 0.21% 134
2019
Q3
Sell
-5,043
Closed -$925K 1453
2019
Q2
$925K Sell
5,043
-14,660
-74% -$2.69M 0.01% 962
2019
Q1
$3.62M Sell
19,703
-1,675
-8% -$308K 0.02% 572
2018
Q4
$3.54M Buy
21,378
+5,373
+34% +$890K 0.03% 504
2018
Q3
$3.09M Buy
+16,005
New +$3.09M 0.01% 676
2018
Q1
Sell
-347,312
Closed -$52M 2046
2017
Q4
$52M Buy
347,312
+155,682
+81% +$23.3M 0.16% 142
2017
Q3
$29.1M Sell
191,630
-200,462
-51% -$30.5M 0.11% 211
2017
Q2
$50.5M Buy
392,092
+126,175
+47% +$16.3M 0.21% 108
2017
Q1
$29.1M Buy
265,917
+170,261
+178% +$18.6M 0.14% 180
2016
Q4
$7.05M Buy
95,656
+5,652
+6% +$416K 0.04% 485
2016
Q3
$7.85M Buy
90,004
+5,519
+7% +$481K 0.05% 429
2016
Q2
$7.27M Sell
84,485
-14,225
-14% -$1.22M 0.05% 351
2016
Q1
$7.85M Sell
98,710
-396,600
-80% -$31.5M 0.05% 355
2015
Q4
$62.3M Buy
495,310
+426,304
+618% +$53.6M 0.43% 46
2015
Q3
$7.19M Buy
+69,006
New +$7.19M 0.05% 369
2013
Q3
Sell
-55,000
Closed -$4.4M 569
2013
Q2
$4.4M Buy
+55,000
New +$4.4M 0.07% 242